Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Proposed listing date: 12 AUGUST 2021 12:00PM AEST ##
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CNR | Phoenix Administration CNR Entitlement Claim - Legit? | 24/09/24 | 1 | 952 | |||
|
|||||||
CNR | News: CNR ASX Says Cannon Resources Will Be Removed From Official List On 7 Feb | 15/02/23 | 1 | 1.8K | |||
|
|||||||
CNR | Ann: Removal from Official List | 07/02/23 | 0 | 817 | |||
|
|||||||
CNR | Ann: Suspension from Quotation | 02/02/23 | 0 | 695 | |||
|
|||||||
CNR | Ann: Quarterly Cash Flow Report - December 2022 | 31/01/23 | 0 | 508 | |||
|
|||||||
CNR | Ann: Quarterly Activities Report - December 2022 | 31/01/23 | 0 | 489 | |||
|
|||||||
CNR | Ann: Compulsory acquisition notice | 25/01/23 | 0 | 1.0K | |||
|
|||||||
CNR | Ann: Final Director's Interest Notice - Richard Bevan | 25/01/23 | 0 | 408 | |||
|
See All Discussions